Contact us | Bronchiectasis Info | Rethinkbronchiectasis

Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endo-typing, genetics, microbiome, and disease heterogeneity. Lancet. 2018;392(10150):880–890.
Dente FL, Bilotta M, Bartoli ML, et al. Neutrophilic bronchial inflammation correlates with clinical and functional findings in patients with noncystic fibrosis bronchiectasis. Mediators Inflamm. 2015;2015:642503.
Effah CY, Drokow EK, Agboyibor C, et al. Neutrophil-dependent immunity during pulmonary infections and inflammations. Front Immunol. 2021;12:689866.
Rosales C. Neutrophils at the crossroads of innate and adaptive immunity. J Leukoc Biol. 2020;108(1):377–396.
Keir HR, Chalmers JD. Pathophysiology of bronchiectasis. Semin Respir Crit Care Med. 2021;42(4):499–512.
Chalmers JD, Moffitt KL, Suarez-Cuartin G, et al. Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis. Am J Respir Crit Care Med. 2017;195(10):1384–1393.
Chalmers JD, Chang AB, Chotirmall SH, et al. Bronchiectasis. Nat Rev Dis Primers. 2018;4(1):45.
Aliberti S, Goeminne PC, O’Donnell AE, et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med. 2022;10(3):298–306.
Borekci S, Gundogdu S, Harbiyeli DO, et al. Annual FEV1 Loss in Patients with Noncystic Fibrosis Bronchiectasis and Affecting Factors. South Med J. 2022;115(5):328–332.
Aksamit TR, Lapinel NC, Choate R, et al. Association between bronchiectasis exacerbations and longitudinal changes in FEV1 in patients from the US bronchiectasis and NTM research registry. Respir Med. 2024;228:107660.
Lapinel N, Aksamit TR, Feliciano J, et al. Longitudinal Changes in Forced Expiratory Volume 1 (FEV1) According to Exacerbation Frequency in Patients From the US Bronchiectasis and NTM Research Registry (BRR). Am J Respir Crit Care Med. 2023;207:A4312.
Polverino E, Dimakou K, Hurst J, et al. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J. 2018;52(3):1800328.
Chalmers JD, Sethi S. Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults. NPJ Prim Care Respir Med. 2017;27(1):18.
O’Donnell AE. Bronchiectasis – a clinical review. N Engl J Med. 2022;387(6):533–545.
Chan ED, Wooten WI III, Hsieh EWY, et al. Diagnostic evaluation of bronchiectasis. Respir Med X. 2019;1:100006.
Chalmers JD, Aliberti S, Filonenko A, et al. Characterization of the “frequent exacerbator phenotype” in bronchiectasis. Am J Respir Crit Care Med. 2018;197(11):1410–1420.
Hill AT, Haworth CS, Aliberti S, et al; for the EMBARC/BRR definitions working group. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017;49(6):1700051.
Pham CTN. Neutrophil serine proteases fine-tune the inflammatory response. Int J Biochem Cell Biol. 2008;40(6-7):1317–1333.
Bedi P, Davidson DJ, McHugh BJ, et al. Blood neutrophils are reprogrammed in bronchiectasis. Am J Respir Crit Care Med. 2018;198(7):880–890.
Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. Lancet Respir Med. 2018;6(9):715–726.
Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629.

Register to receive updates and information about bronchiectasis

Sign up and stay informed

Next Steps: Install the User Registration Add-On

Register to receive updates and information about bronchiectasis

Sign up and stay informed

Next Steps: Install the User Registration Add-On

You are about to leave Rethink Bronchiectasis

References

This website was developed and funded by Insmed and is intended for healthcare professionals (HCPs) outside the US and the UK only. By entering this site, you are confirming you are an HCP.

You are about to leave Rethink Bronchiectasis